On April 12, 2023 Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company, reported the launch of PhenoCode Discovery Panels, which simplify spatial biology workflows performed on the company’s PhenoCycler-Fusion platform, at the American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting being held in Orlando, Florida, April 14-19, 2023 (Press release, Akoya Biosciences, APR 12, 2023, View Source [SID1234629983]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
PhenoCode Discovery Panels are designed to advance cancer research by enabling thorough interrogation of tumors and the surrounding tumor microenvironment. Each of the ready-to-use, modular panels include biomarkers that can answer key biological questions related to immune profiling, lymphocyte profiling, tissue architecture, and immune activation and proliferation. The panels can be used on their own or combined to explore increasingly complex questions and significantly scale the "plex" of discovery in a stepwise fashion. Upfront assay development and validation time is significantly reduced, accelerating spatial discovery by 3x compared to standard workflows.
"The PhenoCode Discovery Panels further streamline and simplify the workflow on the PhenoCycler-Fusion System, offering new avenues of exploration for existing customers and paving the way for researchers who want to leverage this powerful technology for the first time," said Brian McKelligon, CEO of Akoya. "These panels are an important part of the spatial biology ecosystem which Akoya has established and continues to expand. Our vision is to offer a comprehensive suite of panels for multiple applications. We expect to launch additional PhenoCode Discovery Panels for protein biomarkers throughout 2023 and 2024, and introduce panels for RNA in the second half of this year."
The PhenoCode Discovery Panels will be highlighted at booth #1713 at AACR (Free AACR Whitepaper). More than a dozen posters describing use of the company’s spatial biology solutions will be shared at AACR (Free AACR Whitepaper) by Akoya scientists and collaborators.
Akoya scientists and collaborators will also share spatial biology case studies on the use of high plex spatial phenotyping to reveal new insights into tumor progression and treatment response in a spotlight session at AACR (Free AACR Whitepaper). Details of the presentation are as follows:
Date/Time: Monday, April 17, 2023, 10:00 AM
Location: Spotlight Theater C
Speakers:
Rajkumar Savai, PhD, Professor of Lung Microenvironmental Niche in Cancerogenesis, Max-Planck-Institute for Heart and Lung Research and Institute for Lung Health (ILH)
Jasmine Plummer, PhD Founding Director, Center for Spatial Omics, St. Jude Children’s Research Hospital
Oliver Braubach, PhD, Director of Applications, Akoya Biosciences
More details about Akoya’s AACR (Free AACR Whitepaper) activities and poster presentations can be found here.